Anti-MOG Antibody Syndrome and Cerebral Sinovenous Thrombosis: A Cause–Effect HypothesisFunding None.
Cerebral venous thrombosis is an uncommon event of stroke in childhood. Its origin is multifactorial and often it manifests with nonspecific symptoms that may overlap with underlying predisposing factors. Anti–myelin oligodendrocyte glycoprotein (MOG) antibody syndrome is a group of recently recognized acquired demyelinating diseases that occur more commonly in children, usually, with a favorable outcome. The association between cerebral venous thrombosis and demyelinating syndrome has been reported but their clinical relationship is matter of debate and various hypotheses have been advanced including intravenous (IV) steroid therapy and/or the consequence of a shared inflammatory-thrombotic process. Herein, we report the case of a child with anti-MOG antibody syndromes who developed a thrombosis of the superior sagittal sinus and of the right Trolard's vein.
Keywordsanti-MOG antibody - cerebral sinovenous thrombosis - visual impairment - pseudotumor cerebri - lumbar puncture
A.F., P.S., F.G., A. F., P.P., and A.D.P. reviewed the literature, critically discussed various aspects of epilepsy in pediatric patients, and read the manuscript.
Received: 25 May 2020
Accepted: 25 July 2020
07 September 2020 (online)
Georg Thieme Verlag KG
Stuttgart · New York
- 1 Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am 2010; 21 (03) 511-527
- 2 Zhao T, Wang G, Dai J, Liu Y, Wang Y, Li S. Cases of visual impairment caused by cerebral venous sinus occlusion-induced intracranial hypertension in the absence of headache. BMC Neurol 2018; 18 (01) 159
- 3 Chitnis T. Pediatric central nervous system demyelinating diseases. Continuum (Minneap Minn) 2019; 25 (03) 793-814
- 4 Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 2019; 15 (02) 89-102
- 5 Serguera C, Stimmer L, Fovet CM. , et al. Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases. J Neuroinflammation 2019; 16 (01) 244
- 6 Koudriavtseva T, Renna R, Plantone D, Mainero C. Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors. Front Neurol 2015; 6: 63
- 7 Soto-Insuga V, Salvador TA, Martinez LC. , et al. Anti-myelin oligodendrocyte glycoprotein autoantibodies in optic neuritis and venous sinus thrombosis in a girl. J Pediatr Neurol and Med 2016; 1: 109
- 8 Jarius S, Ruprecht K, Kleiter I. , et al; in cooperation with the Neuromyelitis Optica Study Group (NEMOS). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 2016; 13 (01) 280
- 9 Vandenberghe N, Debouverie M, Anxionnat R, Clavelou P, Bouly S, Weber M. Cerebral venous thrombosis in four patients with multiple sclerosis. Eur J Neurol 2003; 10 (01) 63-66
- 10 van Zaane B, Nur E, Squizzato A. , et al. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost 2010; 8 (11) 2483-2493
- 11 Cakmak S, Derex L, Berruyer M. , et al. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology 2003; 60 (07) 1175-1178
- 12 Stokes S, Breheny P, Radulescu A, Radulescu VC. Impact of obesity on the risk of venous thromboembolism in an inpatient pediatric population. Pediatr Hematol Oncol 2014; 31 (05) 475-480
- 13 Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81 (13) 1159-1165
- 14 Giacomini T, Foiadelli T, Annovazzi P. , et al. Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients. Mult Scler Relat Disord 2019; 39: 101917
- 15 Fernandez-Carbonell C, Vargas-Lowy D, Musallam A. , et al. Clinical and MRI phenotype of children with MOG antibodies. Mult Scler 2016; 22 (02) 174-184